| # | Drug | Count |
|---|---|---|
| 0 | PEGCETACOPLAN | 8 |
| 1 | BEVACIZUMAB | 2 |
| 2 | LEVOTHYROXINE SODIUM | 2 |
| 3 | POVIDONE-IODINE | 2 |
| 4 | ACETAZOLAMIDE | 1 |
| 5 | ACETAZOLAMIDE SODIUM | 1 |
| 6 | BRIMONIDINE | 1 |
| 7 | BRIMONIDINE TARTRATE | 1 |
| 8 | DEXAMETHASONE | 1 |
| 9 | DEXAMETHASONE 1.5 MG | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PEGCETACOPLAN | 8 | 0.0042 |
| 1 | TEBENTAFUSP | 1 | 0.0017 |
| 2 | DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE OPHTHALMIC SOLUTION | 1 | 0.0013 |
| 3 | POVIDONE-IODINE | 2 | 0.0005 |
| 4 | ACETAZOLAMIDE SODIUM | 1 | 0.0002 |
| 5 | DORZOLAMIDE | 1 | 0.0001 |
| 6 | PREDNISOLONE ACETATE | 1 | 0.0001 |
| 7 | TIMOLOL | 1 | 0.0001 |
| 8 | LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN | 1 | 0.0001 |
| 9 | BRIMONIDINE TARTRATE | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC] | 1 | 0.0017 |
| 1 | Antiseptic [EPC] | 2 | 0.0005 |
| 2 | Complement Inhibitor [EPC] | 8 | 0.0001 |
| 3 | Radioligand Therapeutic Agent [EPC] | 1 | 0.0001 |
| 4 | Carbonic Anhydrase Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 6 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 2 | 0.0000 |
| 7 | Sulfonylurea [EPC] | 1 | 0.0000 |
| 8 | Corticosteroid [EPC] | 1 | 0.0000 |